XLR11-d5 (exempt preparation)

XLR11-d₅ (exempt preparation) is intended for use as an internal standard for the quantification of XLR11 by GC- or LC-MS. XLR11 is characterized as a synthetic cannabinoid.¹ XLR11 is regulated as a Schedule 1 compound in the United States. XLR11-d₅ (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

[1] Banister, S.D., Stuart, J., Kevin, R.C., et al. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135 ACS Chem. Neurosci. 6(8),1445-1458(2015).
[2] CAITLYN NORMAN. In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH-PIATA, a new indole-3-acetamide synthetic cannabinoid[J]. Drug Testing and Analysis, 2023, 16 4: 380-391. DOI: 10.1002/dta.3555